ZINZANI, PIER LUIGI
ZINZANI, PIER LUIGI
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE
Docenti di ruolo di Ia fascia
P. L. Zinzani; ZINZANI L; [Zinzani PL]; P. ZINZANI; ZINZANI P; ZINZANI P.L.
(90) Y-ibritumomab tiuxetan in patients with extra-nodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) - The Zeno Study
2020 Lolli, Ginevra; Argnani, Lisa; Broccoli, Alessandro; Marangon, Miriam; Pellegrini, Cinzia; Morigi, Alice; Casadei, Beatrice; Nanni, Laura; Stefoni, Vittorio; Carella, Matteo; Cavo, Michele; Zinzani, Pier L
18 F-FDG PET in malignant lymphoma: significance of positive findings
2005 Castellucci P.; Zinzani P.L.; Nanni C.; Farsad M.; Moretti A.; Alinari L.; Battista G.; Tani M.; Stefoni V.; Canini R.; Monetti N.; Rubello D.; Alavi A.; Franchi R.; Fanti S.
18[F]FDG small animal PET study of sorafenib efficacy in lymphoma preclinical models.
2010 Ambrosini V; Quarta C; Zinzani PL; Nanni C; Fini M; Torricelli P; Giavaresi G; D'Errico-Grigioni A; Malvi D; Franchi R; Fanti S.
18F-FDG PET early after radiotherapy in lymphoma patients.
2004 CASTELLUCCI P; ZINZANI P; NANNI C; FARSAD M; MORETTI A; ALINARI L; BATTISTA G; PETTINATO C; MARENGO M; BOSCHI S; CANINI R; BACCARANI M.; MONETTI N; FANTI S.
18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma.
2006 Alinari L; Castellucci P; Elstrom R; Ambrosini V; Stefoni V; Nanni C; Berkowitz A; Tani M; Farsad M; Franchi R; Fanti S; Zinzani PL.
18f-FDG small animal PET for early detection of human anaplastic large cell lynphoma xenografts in immunocompromised mice
2008 Ambrosini V.; Quarto C.; Zinzani P.L.; Fini M.; Giavaresi G.; Torricelli P.; Malvi D.; Nanni C.; Grassetto G.; Rubellos D.; Fanti S.
90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years
2016 Casadei, Beatrice; Pellegrini, Cinzia; Pulsoni, Alessandro; Annechini, Giorgia; De Renzo, Amalia; Stefoni, Vittorio; Broccoli, Alessandro; Gandolfi, Letizia; Quirini, Federica; Tonialini, Lorenzo; Morigi, Alice; Argnani, Lisa; Zinzani, Pier Luigi
90Y-ibritumumab tiuxetan (Zevalin)
2008 Zinzani P.L.
[18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study.
2014 M. Martelli;L. Ceriani;E. Zucca;P. L. Zinzani;A. J. M;U. Vitolo;C. Stelitano;E. Brusamolino;M. G. Cabras;L. Rigacci;M. Balzarotti;F. Salvi;S. Montoto;A. Lopez-Guillermo;E. Finolezzi;S. A. Pileri;A. Davies;F. Cavalli;L. Giovanella;P. W. M
A 3-decade multicenter European experience with cladribine as upfront treatment in 384 hairy cell leukemia patients
2022 Broccoli, Alessandro; Argnani, Lisa; Cross, Matthew; Janus, Agnieszka; Maitre, Elsa; Troussard, Xavier; Robak, Tadeusz; Dearden, Claire; Else, Monica; Catovsky, Daniel; Zinzani, Pier Luigi
A 3-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphoma
2021 Derenzini E, Mazzara S, Melle F, Motta G, Fabbri M, Bruna R, Agostinelli C, Cesano A, Corsini CA, Chen N, Righi S, Sabattini E, Chiappella A, Calleri A, Fiori S, Tabanelli V, Cabras A, Pruneri G, Vitolo U, Gianni AM, Rambaldi A, Corradini P, Zinzani PL, Tarella C, Pileri S.
A Case of Bing-Neel Syndrome Treated Successfully With Ibrutinib Monotherapy Following Intensive Chemoimmunotherapy
2021 Carella M.; Stefoni V.; Broccoli A.; Argnani L.; Zinzani P.L.
A case of pityriasis lichenoides et varioliformis acuta developed after first dose of Oxford-AstraZeneca COVID-19 vaccine
2022 Filippi, F; Baraldi, C; Zinzani, P L; Casadei, B; Pileri, A
A case report of the long treatment experience of a Sézary syndrome responder patient: 16 years through all the systemic and innovative therapies
2019 Nanni, Laura; Morigi, Alice; Casadei, Beatrice; Broccoli, Alessandro; Stefoni, Vittorio; Argnani, Lisa; Cavo, Michele; Zinzani, Pier Luigi
A multicenter phase II trial (SAKK 36/06) of single-agent Everolimus(RAD001) in patients with relapsed or refractory mantle cell lymphoma.
2012 Renner C; Zinzani P.L.; Gressin R; Klingbiel D; Dietrich PY; Hitz F; Bargetzi M; Mingrone W; Martinelli G; Trojan A; Bouabdallah K; Lohri A; Gyan E; Biaggi C; Cogliatti S; Bertoni F; Ghielmini M; Brauchli P; Ketterer N.
A patient with plasmablastic lymphoma achieving long-term complete remission after thalidomide-dexamethasone induction and double autologous stem cell transplantation: a case report
2018 Broccoli, Alessandro; Nanni, Laura; Stefoni, Vittorio; Agostinelli, Claudio; Argnani, Lisa; Cavo, Michele; Zinzani, Pier Luigi
A phase 1/2, open-label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma
2022 Carlo-Stella C.; Zinzani P.L.; Sureda A.; Araujo L.; Casasnovas O.; Carpio C.; Yeh S.-P.; Bouabdallah K.; Cartron G.; Kim W.S.; Cordoba R.; Koh Y.; Re A.; Alves D.; Chamuleau M.; Le Gouill S.; Lopez-Guillermo A.; Moreira I.; van der Poel M.W.M.; Abbadessa G.; Meng R.; Ji R.; Lepine L.; Saleem R.; Ribrag V.
A phase 2 trial of fludarabine and mitoxantrone chemoterapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma
2008 Zinzani P.L.; Tani M.; Fanti S.; Stefoni V.; Musuraca G.; Vitolo U.; Perrotti A.; Fina M.; Derenzini E.; Baccarani M.
A Phase 2/3 Multicenter, Randomized, Open-Label Study of Lenalidomide vs Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
2017 Czuczman, Myron S; Trněný, Marek; Davies, Andrew; Rule, Simon Aj; Linton, Kim; Wagner-Johnston, Nina; Gascoyne, Randy D; Slack, Graham; Brousset, Pierre; Eberhard, David A; Hernandez-Ilizaliturri, Francisco J; Salles, Gilles; Witzig, Thomas E; Zinzani, Pier Luigi; Wright, George W; Staudt, Louis M; Yang, Yandan; Williams, P Michael; Lih, Chih-Jian; Russo, Jacqueline; Thakurta, Anjan; Hagner, Patrick; Fustier, Pierre; Song, Dale; Lewis, Ian D
A Phase II international, multicenter study of oral panobinostat (LBH589) in patients with refractory cutaneous T-cell lymphoma
2008 Bernengo M.G.; Vanaclocha F.; Duvic M.; Kuzel T.; Kerdel F.; Pinter-Brown L.; Bosly A.; Okada C.; Breneman D.; Zinzani P.L.; Becker J.; Hughey L.; Ardaiz M.; Zain J.; Zhang L.; Hirawat S.; Laird G.; Johnson D.; Prince H.M.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| (90) Y-ibritumomab tiuxetan in patients with extra-nodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) - The Zeno Study | Lolli, Ginevra; Argnani, Lisa; Broccoli, Alessandro; Marangon, Miriam; Pellegrini, Cinzia; Morigi..., Alice; Casadei, Beatrice; Nanni, Laura; Stefoni, Vittorio; Carella, Matteo; Cavo, Michele; Zinzani, Pier L | 2020-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| 18 F-FDG PET in malignant lymphoma: significance of positive findings | Castellucci P.; Zinzani P.L.; Nanni C.; Farsad M.; Moretti A.; Alinari L.; Battista G.; Tani M.; ...Stefoni V.; Canini R.; Monetti N.; Rubello D.; Alavi A.; Franchi R.; Fanti S. | 2005-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| 18[F]FDG small animal PET study of sorafenib efficacy in lymphoma preclinical models. | Ambrosini V; Quarta C; Zinzani PL; Nanni C; Fini M; Torricelli P; Giavaresi G; D'Errico-Grigioni ...A; Malvi D; Franchi R; Fanti S. | 2010-01-01 | THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| 18F-FDG PET early after radiotherapy in lymphoma patients. | CASTELLUCCI P; ZINZANI P; NANNI C; FARSAD M; MORETTI A; ALINARI L; BATTISTA G; PETTINATO C; MAREN...GO M; BOSCHI S; CANINI R; BACCARANI M.; MONETTI N; FANTI S. | 2004-01-01 | CANCER BIOTHERAPY & RADIOPHARMACEUTICALS | - | 1.01 Articolo in rivista | - |
| 18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma. |
Alinari L; Castellucci P; Elstrom R; Ambrosini V; Stefoni V; Nanni C; Berkowitz A; Tani M; Farsa...d M; Franchi R; Fanti S; Zinzani PL. |
2006-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| 18f-FDG small animal PET for early detection of human anaplastic large cell lynphoma xenografts in immunocompromised mice | Ambrosini V.; Quarto C.; Zinzani P.L.; Fini M.; Giavaresi G.; Torricelli P.; Malvi D.; Nanni C.; ...Grassetto G.; Rubellos D.; Fanti S. | 2008-01-01 | ANTICANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| 90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years | Casadei, Beatrice; Pellegrini, Cinzia; Pulsoni, Alessandro; Annechini, Giorgia; De Renzo, Amalia;... Stefoni, Vittorio; Broccoli, Alessandro; Gandolfi, Letizia; Quirini, Federica; Tonialini, Lorenzo; Morigi, Alice; Argnani, Lisa; Zinzani, Pier Luigi | 2016-01-01 | CANCER MEDICINE | - | 1.01 Articolo in rivista | cam4.684.pdf |
| 90Y-ibritumumab tiuxetan (Zevalin) | Zinzani P.L. | 2008-01-01 | HEMATOLOGY MEETING REPORTS | - | 1.01 Articolo in rivista | - |
| [18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study. | M. Martelli;L. Ceriani;E. Zucca;P. L. Zinzani;A. J. M;U. Vitolo;C. Stelitano;E. Brusamolino;M. G.... Cabras;L. Rigacci;M. Balzarotti;F. Salvi;S. Montoto;A. Lopez-Guillermo;E. Finolezzi;S. A. Pileri;A. Davies;F. Cavalli;L. Giovanella;P. W. M | 2014-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| A 3-decade multicenter European experience with cladribine as upfront treatment in 384 hairy cell leukemia patients | Broccoli, Alessandro; Argnani, Lisa; Cross, Matthew; Janus, Agnieszka; Maitre, Elsa; Troussard, X...avier; Robak, Tadeusz; Dearden, Claire; Else, Monica; Catovsky, Daniel; Zinzani, Pier Luigi | 2022-01-01 | BLOOD ADVANCES | - | 1.01 Articolo in rivista | advancesADV2022007854-suppl1.pdf; advancesadv2022007854.pdf |
| A 3-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphoma | Derenzini E, Mazzara S, Melle F, Motta G, Fabbri M, Bruna R, Agostinelli C, Cesano A, Corsini CA,... Chen N, Righi S, Sabattini E, Chiappella A, Calleri A, Fiori S, Tabanelli V, Cabras A, Pruneri G, Vitolo U, Gianni AM, Rambaldi A, Corradini P, Zinzani PL, Tarella C, Pileri S. | 2021-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| A Case of Bing-Neel Syndrome Treated Successfully With Ibrutinib Monotherapy Following Intensive Chemoimmunotherapy | Carella M.; Stefoni V.; Broccoli A.; Argnani L.; Zinzani P.L. | 2021-01-01 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | - | 1.01 Articolo in rivista | - |
| A case of pityriasis lichenoides et varioliformis acuta developed after first dose of Oxford-AstraZeneca COVID-19 vaccine | Filippi, F; Baraldi, C; Zinzani, P L; Casadei, B; Pileri, A | 2022-01-01 | JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | - | 1.01 Articolo in rivista | - |
| A case report of the long treatment experience of a Sézary syndrome responder patient: 16 years through all the systemic and innovative therapies | Nanni, Laura; Morigi, Alice; Casadei, Beatrice; Broccoli, Alessandro; Stefoni, Vittorio; Argnani,... Lisa; Cavo, Michele; Zinzani, Pier Luigi | 2019-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| A multicenter phase II trial (SAKK 36/06) of single-agent Everolimus(RAD001) in patients with relapsed or refractory mantle cell lymphoma. | Renner C; Zinzani P.L.; Gressin R; Klingbiel D; Dietrich PY; Hitz F; Bargetzi M; Mingrone W; Mart...inelli G; Trojan A; Bouabdallah K; Lohri A; Gyan E; Biaggi C; Cogliatti S; Bertoni F; Ghielmini M; Brauchli P; Ketterer N. | 2012-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| A patient with plasmablastic lymphoma achieving long-term complete remission after thalidomide-dexamethasone induction and double autologous stem cell transplantation: a case report | Broccoli, Alessandro; Nanni, Laura; Stefoni, Vittorio; Agostinelli, Claudio; Argnani, Lisa; Cavo,... Michele; Zinzani, Pier Luigi | 2018-01-01 | BMC CANCER | - | 1.01 Articolo in rivista | s12885-018-4561-9.pdf |
| A phase 1/2, open-label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma | Carlo-Stella C.; Zinzani P.L.; Sureda A.; Araujo L.; Casasnovas O.; Carpio C.; Yeh S.-P.; Bouabda...llah K.; Cartron G.; Kim W.S.; Cordoba R.; Koh Y.; Re A.; Alves D.; Chamuleau M.; Le Gouill S.; Lopez-Guillermo A.; Moreira I.; van der Poel M.W.M.; Abbadessa G.; Meng R.; Ji R.; Lepine L.; Saleem R.; Ribrag V. | 2022-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| A phase 2 trial of fludarabine and mitoxantrone chemoterapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma | Zinzani P.L.; Tani M.; Fanti S.; Stefoni V.; Musuraca G.; Vitolo U.; Perrotti A.; Fina M.; Derenz...ini E.; Baccarani M. | 2008-01-01 | CANCER | - | 1.01 Articolo in rivista | - |
| A Phase 2/3 Multicenter, Randomized, Open-Label Study of Lenalidomide vs Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma | Czuczman, Myron S; Trněný, Marek; Davies, Andrew; Rule, Simon Aj; Linton, Kim; Wagner-Johnston, N...ina; Gascoyne, Randy D; Slack, Graham; Brousset, Pierre; Eberhard, David A; Hernandez-Ilizaliturri, Francisco J; Salles, Gilles; Witzig, Thomas E; Zinzani, Pier Luigi; Wright, George W; Staudt, Louis M; Yang, Yandan; Williams, P Michael; Lih, Chih-Jian; Russo, Jacqueline; Thakurta, Anjan; Hagner, Patrick; Fustier, Pierre; Song, Dale; Lewis, Ian D | 2017-01-01 | CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| A Phase II international, multicenter study of oral panobinostat (LBH589) in patients with refractory cutaneous T-cell lymphoma | Bernengo M.G.; Vanaclocha F.; Duvic M.; Kuzel T.; Kerdel F.; Pinter-Brown L.; Bosly A.; Okada C.;... Breneman D.; Zinzani P.L.; Becker J.; Hughey L.; Ardaiz M.; Zain J.; Zhang L.; Hirawat S.; Laird G.; Johnson D.; Prince H.M. | 2008-01-01 | HEMATOLOGY MEETING REPORTS | - | 1.01 Articolo in rivista | - |